Napoleone Ferrara

Napoleone Ferrara, M.D., Ph.D. is an Italian-American molecular biologist and is currently a Genentech Fellow in tumor biology and angiogenesis. He is credited with identifying the human VEGF gene and describing its proangiogenic properties, which formed the basis for the development of Genentech's bevacizumab and Lucentis monoclonal antibody treatments. For his VEGF discovery, he won a Lasker Award in 2010.^[1]

Education

Dr. Ferrara received his medical degree from the Facoltà di Medicina e Chirurgia dell'Università di Catania (University of Catania Medical School) in Italy in 1981, and joined Genentech in 1988.^[2]

References

1. ^ Strauss, Evelyn. "2010 Winners - Lasker~DeBakey Clinical Medical Research Award". The Lasker Foundation. http://www.laskerfoundation.org/awards/2010_c_description.htm. Retrieved 2010-11-11. 
2. ^ Napoleone Ferrara discusses Avastin and the future of anti-angiogenesis therapy, ScienceDirect.

Persondata
Name	Ferrara, Napoleone
Alternative names
Short description
Date of birth
Place of birth
Date of death
Place of death